Oscar Health Inc. Announces $350 Million Convertible Senior Subordinated Notes Offering, with Option for Additional $52.5 Million
Reuters
Sep 16
Oscar Health Inc. Announces $350 Million Convertible Senior Subordinated Notes Offering, with Option for Additional $52.5 Million
Oscar Health Inc. has announced its intention to offer $350,000,000 aggregate principal amount of convertible senior subordinated notes due 2030 in a private offering to qualified investors. The New York-based company also expects to grant initial purchasers an option to buy an additional $52,500,000 aggregate principal amount of notes, potentially increasing the total value of the issuance. The interest rate, initial conversion rate, and other terms of the notes will be determined at the pricing of the offering. Oscar intends to use the proceeds for general corporate purposes, including strategic AI initiatives and member experience enhancements. Additionally, part of the proceeds will be used to fund capped call transactions to offset share dilution.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oscar Health Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20250915647303) on September 15, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.